About the Company
The Monsanto Company () was an American agrochemical and agricultural biotechnology corporation founded in 1901 and headquartered in Creve Coeur, Missouri. Monsanto's best-known product is Roundup, a glyphosate-based herbicide, developed in the 1970s. Later, the company became a major producer of genetically engineered crops. In 2018, the company ranked 199th on the Fortune 500 of the largest United States corporations by revenue. Monsanto was one of four groups to introduce genes into plants in 1983, and was among the first to conduct field trials of genetically modified crops in 1987. It was one of the top-ten U.S. chemical companies until it divested most of its chemical businesses between 1997 and 2002, through a process of mergers and spin-offs that focused the company on biotechnology. Monsanto was one of the first companies to apply the biotechnology industry business model to agriculture, using techniques developed by biotech drug companies. In this business model, companies recoup R&D expenses by exploiting biological patents. Monsanto's roles in agricultural changes, biotechnology products, lobbying of government agencies, and roots as a chemical company have resulted in controversies. The company once manufactured controversial products such as the insecticide DDT, PCBs, Agent Orange, and recombinant bovine growth hormone. In September 2016, German chemical company Bayer announced its intent to acquire Monsanto for US$66 billion in an all-cash deal. After gaining U.S. and EU regulatory approval, the sale was completed on June 7, 2018. The name Monsanto was no longer used, but Monsanto's previous product brand names were maintained. In June 2020, Bayer agreed to pay numerous settlements in lawsuits involving ex-Monsanto products Roundup, PCBs and Dicamba. Owing to the massive financial and reputational setbacks caused by ongoing litigation concerning Monsanto's herbicide Roundup, the Bayer-Monsanto merger is considered one of the worst corporate mergers in history.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Green Planet Bio Engineering Co. Ltd.
GPLB Green Planet Bioengineering Co., Ltd. - Seeking Alpha
Green Planet Bioengineering Co., Ltd. (GPLB) - 10-Q - Quarterly Report SEC FilingsFri, May 07, 2021 Green Planet Bioengineering Co., Ltd. (GPLB) - 10-K - Annual Report SEC FilingsWed, Mar. 31, 2021 ...
Green Planet Bioengineering Co. Ltd. GPLB (U.S.: OTC) - The Wall Street ...
Green Planet Bioengineering Co. Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View GPLB financial statements in full.
Green Planet Bioengineering Co. Ltd. (GPLB) Stock Price Today - WSJ
View the latest Green Planet Bioengineering Co. Ltd. (GPLB) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Green Planet Bioengineering Co. Ltd. - GPLB | Barron's
Green Planet Bioengineering Co. Ltd. detailed financials by Barron's. View GPLB business summary and company performance, for a clear financial breakdown.
Green Planet Bio Engineering changes auditors By Investing.com
Green Planet Bio Engineering Co. Ltd. (NASDAQ:GPLB), a company specializing in biological products, announced on Thursday significant changes in its financial oversight. The company’s independent ...
GPLB Green Planet Bioengineering Co., Ltd. - Seeking Alpha
The company was formerly known as Mondo Acquisition II, Inc. and changed its name to Green Planet Bioengineering Co., Ltd. on October 02, 2008.
Green Planet Bioengineering Co Ltd (GPLB) - Nasdaq
About Green Planet Bioengineering Co Ltd 20807 BISCAYNE BOULEVARD SUITE 203, AVENTURA, Florida, 33180, United States +1 786 279-2900 ...
Green Planet Bioengineering Co Ltd GPLB - Morningstar
Review quarterly and annual revenue, net income, and cash flow for Green Planet Bioengineering Co Ltd (GPLB:PINX) stock through the last fiscal year.
Similar Companies
Loading the latest forecasts...